58,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
29 °P sammeln
  • Broschiertes Buch

To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications. This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of…mehr

Produktbeschreibung
To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications.
This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types.
Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.


Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Larry K. Golightly, PharmD Clinical Research Pharmacist University of Colorado Hospital Aurora, CO 80045 larry.golightly@uchealth.org   Isaac Teitelbaum, MD, FACP Professor of Medicine Renal Medicine and Hypertension Section, Division of General Internal Medicine University of Colorado School of Medicine and Director, Home Dialysis Program University of Colorado Hospital Aurora, CO 80045 isaac.teitelbaum@cuanschutz.edu   Bonita A. Simendinger, PharmD, BCPS P&T Formulary Compliance Specialist University of Colorado Hospital Aurora, CO 80045 bonita.simendinger@uchealth.org   Tyree H. Kiser, PharmD, BCPS, FCCP, FCCM Professor, Department of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and Critical Care Pharmacy Specialist University of Colorado Hospital Aurora, CO 80045 ty.kiser@cuanschutz.edu   Gerard R. Barber, RPh, MPH, FASHP Clinical Assistant Professor, Department of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora, CO 80045 gerard.barber@cuanschutz.edu   Nancy M. Stolpman, PharmD, PhD Associate Clinical Professor University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and Lead Director of Pharmacy UCHealth Aurora, CO 80045 nancy.stolpman@uchealth.org